Is Innodata Stock's 4.65X PS Still Worth it? Buy, Sell, or Hold? — Negative

INOD   Zacks Investment Research — June 16, 2025

INOD trades at a premium despite underperforming peers YTD, with margin pressure weighing on sentiment.

image for news Is Innodata Stock's 4.65X PS Still Worth it? Buy, Sell, or Hold?

Will CAT's Dividend Hike Revive Investor Confidence in Uncertain Times? — Neutral

CAT   Zacks Investment Research — June 16, 2025

Caterpillar lifts its quarterly dividend by 7% to $1.51, marking 31 straight years of hikes despite recent revenue softness.

image for news Will CAT's Dividend Hike Revive Investor Confidence in Uncertain Times?

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=153322&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Compass Group Diversified Holdings, LLC (CODI) Shareholders of Class Action Lawsuit and July 8, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD

Solve the AI Stock-Picking Burden With This ETF — Positive

QBIG   ETF Trends — June 16, 2025

Investors that are well-acquainted with artificial intelligence (AI) know that some stocks, Nvidia (NVDA) chief among them, are more associated with the “AI stock” label than others. So, it can be argued that separating the AI contenders from the pretenders is an exercise in stock-picking.

image for news Solve the AI Stock-Picking Burden With This ETF

Refresh Your Core Bond Portfolio With Active TAGG — Positive

TAGG   ETF Trends — June 16, 2025

Ratcheting geopolitical tensions in the Middle East mid-June add another layer of risk in 2025. In a tumultuous year defined by ongoing volatility, uncertainty, and risks, actively managed strategies appear well-positioned.

image for news Refresh Your Core Bond Portfolio With Active TAGG

Weekly Economic Snapshot: Inflation Edges Up While Sentiment Rebounds — Neutral

RSP  SPY  XLY   ETF Trends — June 16, 2025

Last week's economic signals were a mix of cautious optimism and renewed concern. While inflation saw a slight uptick in May, it still came in cooler than expected.

image for news Weekly Economic Snapshot: Inflation Edges Up While Sentiment Rebounds

Treasury Yields Snapshot: June 13, 2025 — Neutral

VBIL  VGIT  VGLT   ETF Trends — June 16, 2025

The yield on the 10-year note ended June 13, 2025 at 4.41%. Meanwhile, the 2-year note ended at 3.96% and the 30-year note ended at 4.90%.

image for news Treasury Yields Snapshot: June 13, 2025

Down To Levels Not Seen Since 2016: Initiating Sarepta With A Buy — Neutral

SRPT   Seeking Alpha — June 16, 2025

Sarepta Therapeutics, Inc. plunged over 47% after a second ELEVIDYS-related patient death, raising serious safety concerns and leading to trial suspensions. Despite the negative headlines and slashed FY25 guidance, I see the current valuation as deeply oversold and think long-term investors are best positioned to add at current levels. ELEVIDYS revenue dipped sequentially but remains up 180% year-over-year, and overall product revenue grew 70%, in my opinion, reflecting underlying business strength.

image for news Down To Levels Not Seen Since 2016: Initiating Sarepta With A Buy

Refining margins have improved in the second quarter following the closure of three refineries and unexpected downtime at several domestic refineries. VLO is positioned to maintain its industry leading cost per barrel metric despite an elevated maintenance schedule in Q2. Closure of the Benicia refinery is projected to only increase the company's lead over the industry.

image for news Valero Energy: The Best Operating Margin In The Industry - And Getting Better

BAC, USB & Fifth Third Open to Stablecoins Amid Regulatory Shift — Neutral

BAC  FITB  USB   Zacks Investment Research — June 16, 2025

Bank of America, U.S. Bancorp and Fifth Third signal readiness to adopt stablecoins as bipartisan bills promise clearer U.S. regulation.

image for news BAC, USB & Fifth Third Open to Stablecoins Amid Regulatory Shift

3 Medical Services Stocks Capitalizing on the Healthcare AI Boom — Positive

BTSG  CVS  WGS   Zacks Investment Research — June 16, 2025

CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.

image for news 3 Medical Services Stocks Capitalizing on the Healthcare AI Boom

SEIM: A Still Relatively New Momentum ETF To Keep On The Watchlist — Positive

SEIM   Seeking Alpha — June 16, 2025

SEIM offers a unique blend of momentum and growth, targeting stocks with strong price performance and rising earnings, but comes with elevated volatility. The fund's concentrated portfolio and high beta profile provide strong upside potential, yet also expose investors to greater downside risk and uncorrelated returns. SEIM trades at a premium valuation justified by higher earnings growth, though its profitability slightly lags the benchmark due to sector allocations.

image for news SEIM: A Still Relatively New Momentum ETF To Keep On The Watchlist

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153321&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

image for news Securities Fraud Class Action Filed Against Organon & Co. (OGN) - Levi & Korsinsky Reminds Investors of July 22, 2025

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO

Why Gold Is a Pessimism Bubble About to Burst — Negative

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Barrons — June 16, 2025

Gold is trouncing most other assets. Three experts on why that could change very soon.

image for news Why Gold Is a Pessimism Bubble About to Burst

Here's Why Investors Should Consider Investing in Tetra Tech Stock — Positive

TTEK   Zacks Investment Research — June 16, 2025

TTEK surges 22.4% in three months, fueled by acquisitions, strong federal orders and a bullish FY25 revenue outlook.

image for news Here's Why Investors Should Consider Investing in Tetra Tech Stock

UPS vs. CPA: Which Dividend-Paying Transportation Stock to Bet on Now? — Positive

CPA  UPS   Zacks Investment Research — June 16, 2025

CPA's strong margins, upbeat demand, and rising estimates make it a standout dividend stock over UPS currently.

image for news UPS vs. CPA: Which Dividend-Paying Transportation Stock to Bet on Now?

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=153320&wire=1&utm_campaign=3 or contact Joseph E.

image for news Securities Lawsuit Alert: Bitfarms Ltd. (BITF) - Contact Levi & Korsinsky Before July 8, 2025

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

image for news Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.